Background: A difference with regard to the correlation with coronary atherosclerosis (CAS) between extracranial carotid atherosclerosis (ECAS) and intracranial cerebral atherosclerosis (ICAS) has been assumed but not proven clearly by direct comparison within the same population. Methods: A consecutive series of 246 patients undergoing coronary artery bypass graft surgery were reviewed. The severity of CAS was estimated as a CAS score based on coronary angiography. The presence of ECAS and ICAS was screened by transcranial Doppler and carotid duplex sonography, and confirmed by magnetic resonance angiography. Results: The CAS scores in patients with ECAS were observed to be higher than those in patients without ECAS (10.62 ± 4.80 vs. 9.45 ± 4.25; p = 0.054 on the Mann-Whitney U test). The difference in CAS scores was smaller between patients with and without ICAS (10.41 ± 4.44 vs. 9.66 ± 4.49; p = 0.201). Similar patterns were observed on comparing the correlation of ECAS and ICAS with a quartile of the CAS score. An advanced CAS, which was generated by collapsing the quartiles of the CAS score into 75th percentile or less and more than the 75th percentile, was significantly associated with ECAS, but not with ICAS. These associations remained unchanged after adjustments had been made for age, sex, hypertension, diabetes mellitus, hyperlipidemia, smoking and a history of stroke or transient ischemic attack. Conclusions: This study suggests that the correlation of CAS with ECAS is stronger than that of CAS with ICAS, and this difference is independent of the classic risk factors for atherosclerosis.

Keywords:
Intracranial atherosclerosis, Coronary atherosclerosis, Carotid atherosclerosis, Coronary artery bypass
1.
Mitchell JRA, Schwartz CJ: Relationship between arterial disease in different sites: a study of the aorta and coronary, carotid and iliac arteries. BMJ 1962;1293–1301.
2.
Mathur KS, Kashyap MB, Kumar V: Correlation of the extent and severity of atherosclerosis in the coronary and cerebral arteries. Circulation 1963;27:929–934.
3.
Craven TE, Ryu JE, Espeland MA, Kahl FR, Mckinney WM, Toole JF, McMahan MR, Thompson CJ, Heiss G, Crouse JR III: Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis: a case-control study. Circulation 1990;82:1230–1242.
4.
Chen WH, Ho DSW, Ho SL, Cheung RTF, Cheng SWK: Prevalence of extracranial carotid and vertebral artery disease in Chinese patients with coronary artery disease. Stroke 1998;29:631–634.
5.
Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, Azen SP: The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998;128:262–269.
6.
Crouse JR, Toole JF, McKinney WM, Dignan MB, Howard G, Kahl FR, McMahan MR, Harpold GH: Risk factors for extracranial carotid artery atherosclerosis. Stroke 1987;18:990–996.
7.
Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B: Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996;27:1974–1980.
8.
Caplan LR, Gorelick BP, Hier PB: Race, sex and occlusive disease: a review. Stroke 1986;17:648–655.
9.
Gorelick PB, Caplan LR, Hier DB, Parker SL, Patel D: Racial difference in the distribution of anterior circulation occlusive disease. Neurology 1984;34:54–59.
10.
Kuller L, Reisler D: An explanation for variations in distribution of stroke and arteriosclerotic heart disease among populations and racial group. Am J Epidemiol 1971;93:1–9.
11.
Uehara T, Tabuchi M, Hayashi T, Kurogane H, Yamadori A: Asymptomatic occlusive lesions of carotid and intracranial arteries in Japanese patients with ischemic heart disease. Stroke 1996;27:393–397.
12.
Uehara T, Tabuchi M, Kozawa S, Mori E: MR angiographic evaluation of carotid and intracranial arteries in Japanese patients scheduled for coronary artery bypass grafting. Cerebrovasc Dis 2001;11:341–345.
13.
Leung SY, Ng THK, Yuen ST, Lauder IJ, Ho FCS: Pattern of cerebral atherosclerosis in Hong Kong Chinese: severity in intracranial and extracranial vessels. Stroke 1993;24:779–786.
14.
Uehara T, Tobuchi M, Mori E: Frequency and clinical correlates of occlusive lesions of cerebral arteries in Japanese patients without stroke. Cerebrovasc Dis 1998;8:267–272.
15.
Suwanwela NC, Chutinetr A: Risk factors for atherosclerosis of cervicocerebral arteries: intracranial versus extracranial. Neuroepidemiology 2003;22:37–40.
16.
Yasaka M, Yamaguchi T, Shichiri M: Distribution of atherosclerosis and risk factors in atherothrombotic occlusion. Stroke 1993;24:206–211.
17.
Lee SJ, Cho SJ, Moon HS, Shon YM, Lee KH, Kim DI, Lee BB, Byun HS, Han SH, Chung CS: Combined extracranial and intracranial atherosclerosis in Korean patients. Arch Neurol 2003;60:1561–1564.
18.
Yoon BW, Bae HJ, Kang DW, Lee SH, Hong KS, Kim KB, Park BJ, Roh JK: Intracranial cerebral artery disease as a risk factor for central nervous system complications of coronary artery bypass graft surgery. Stroke 2001;32:94–99.
19.
Jenkins PJ, Harper RW, Nestel PJ: Severity of coronary atherosclerosis related to lipoprotein concentration. BMJ 1978;2:388–391.
20.
North American Symptomatic Carotid Endarterectomy Trial (NASCET) Steering Committee: North American Symptomatic Carotid Endarterectomy Trial: methods, patient characteristics, and progress. Stroke 1991;22:711–720.
21.
Lakka TA, Lakka HM, Salonen R, Kaplan GA, Salonen JT: Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men. Atherosclerosis 2001;154:497–504.
22.
Bokemark L, Wikstrand J, Attvall S, Hulthe J, Wedel H, Fagerberg B: Insulin resistance and intima-media thickness in the carotid and femoral arteries of clinically healthy 58-year-old men. The Atherosclerosis and Insulin Resistance Study (AIR). J Intern Med 2001;249:59–67.
23.
Willineck WA, Ludwig M, Lennarz M, Holler T, Stumpe KO: High-normal serum homocysteine concentrations are associated with an increased risk of early atherosclerotic carotid artery wall lesions in healthy subjects. J Hypertens 2000;18:425–430.
24.
Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, Muggeo M, Xu Q, Wick G, Poewe W, Willeit J: Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001;103:1064–1070.
25.
Wang TJ, Nam BH, Wilson PWF, Wolf PA, Levy D, Polak JF, D’Agostino RB, O’Donnell CJ: Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2002;22:1662–1667.
26.
Fruchart JC, Nierman MC, Stroes ES, Kastelein JJ, Duriez P: New risk factors for atherosclerosis and patient risk assessment. Circulation 2004;109(suppl 1):III15–III19.
27.
Novelli G, Borgiani P, Giardina E, Mango R: Role of genetics in prevention of coronary atherosclerosis. Curr Opin Cardiol 2003;18:368–371.
28.
Grant PJ: The genetics of atherothrombotic disorders: a clinician’s view. J Thromb Haemost 2003;1:1381–1390.
29.
Humphries SE, Morgan L: Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches. Lancet Neurol 2004;3:227–236.
30.
Stephens JW, Humphries SE: The molecular genetics of cardiovascular disease: clinical implications. J Intern Med 2003;253:120–127.
31.
Lusis AJ, Fogelman AM, Fonarow GC: Genetic basis of atherosclerosis. II. Clinical implications. Circulation 2004;110:2066–2071.
32.
Aronow WS: C-reactive protein: should it be considered a coronary risk factor? Geriatrics 2003;58:19–22.
33.
Resch JA, Baker AB: Etiologic mechanisms in cerebral atherosclerosis. Arch Neurol 1964;90:617–628.
34.
Funabashi N, Kobayashi Y, Perlroth M, Rubin GD: Coronary artery: quantitative evaluation of normal diameter determined with electron-beam CT compared with cine coronary angiography initial experience. Radiology 2003;226:263–271.
35.
Mohr JP: Internal carotid artery disease; in Barnett HJM, Mohr JP, Stein BM, Yatsu FM (eds): Stroke: Pathophysiology, Diagnosis, and Management, ed 3. Philadelphia, Churchill Livingstone, 1998, pp 355–400.
36.
Mohr JP, Lazar RM, Marshall RS, Gautier JC, Hier DB: Middle cerebral artery disease; in Barnett HJM, Mohr JP, Stein BM, Yatsu FM (eds): Stroke: Pathophysiology, Diagnosis, and Management, ed 3. Philadelphia, Churchill Livingstone, 1998, pp 427–479.
37.
D’Armiento FP, Bianchi A, de Nigris F, Capuzzi DM, D’Armiento MR, Crimi G, Abete P, Palinski W, Condorelli M, Napoli C: Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis. Stroke 2001;32:2472–2479.
38.
Fisher CM, Gore I, Okabe N, White PD: Atherosclerosis of the carotid and vertebral arteries – Extracranial and intracranial. J Neuropathol Exp Neurol 1965;24:455–476.
39.
Nikolaou K, Poon M, Sirol M, Becker CR, Fayad ZA: Complementary results of computed tomography and magnetic resonance imaging of the heart and coronary arteries: a review and future outlook. Cardiol Clin 2003;21:639–655.
40.
Carriero A, Ucchino S, Magarelli N, Legnini M, Marcri MA, Napolitano AM, Bonomo L: Carotid bifurcation stenosis: a comparative study between MR angiography and duplex scanning with respect to digital subtraction angiography. J Neuroradiol 1995;22:103–111.
41.
Alexandrov AV, Memchuk AM, Wein TH, Grotta JC: Yield of transcranial Doppler in acute cerebral ischemia. Stroke 1999;30:1604–1609.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.